Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Beta Thalassemia
NCT03183375Phase 2Unknown
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in beta thalassemia. Status: unknown.
02
Drugs
hydroxyurea
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT03183375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183375.